Australian Pharmaceuticals & Biotech Fast Growing Stocks With High Insider Ownership

Acrux

Market Cap: AU$5.7m

Develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally.

EZZ Life Science Holdings

Market Cap: AU$119.3m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.

Mesoblast

Market Cap: AU$3.3b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Clinuvel Pharmaceuticals

Market Cap: AU$607.0m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

PYC Therapeutics

Market Cap: AU$641.6m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Telix Pharmaceuticals

Market Cap: AU$5.2b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Medical Developments International

Market Cap: AU$76.6m

Manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally.

Aroa Biosurgery

Market Cap: AU$232.9m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.